A systematic review and meta-analysis of randomised controlled trials of surgical treatments for ingrown toenails part II: healing time, post-operative complications, pain, and participant satisfaction.


Journal

Journal of foot and ankle research
ISSN: 1757-1146
Titre abrégé: J Foot Ankle Res
Pays: England
ID NLM: 101471610

Informations de publication

Date de publication:
06 Sep 2023
Historique:
received: 17 03 2023
accepted: 15 08 2023
medline: 8 9 2023
pubmed: 7 9 2023
entrez: 6 9 2023
Statut: epublish

Résumé

When performing nail surgery, clinicians must choose from a multitude of procedures and variations within each procedure. Much has been published to guide this decision making, but there are a lack of up to date robust systematic reviews to assess the totality of this evidence. Five databases (MEDLINE, Embase, CINAHL, Web of Science and CENTRAL) and two registers (Clinicaltrials.gov and ISRCTN) were searched to January 2022 for randomised trials evaluating the effects of a surgical intervention(s) for ingrown toenails. Two independent reviewers screened records, extracted data, assessed risk of bias and certainty of evidence. Data on co-primary outcomes of symptom relief and symptomatic regrowth were presented in our first paper. This paper presents data for the secondary outcomes and further discussion. Of 3,928 records identified, 36 randomised trials were included in the systematic review. Healing time appears to be reduced with shorter application of phenol. A reduced healing time was also apparent was with the addition of curettage, although this may also increase the risk of post-operative bleeding and pain. Post operative bleeding was also reportedly lower in people who received local anaesthetic with epinephrine but no tourniquet. Use of phenol with nail bed excision may decrease the risk of infection. Lower pain scores were reported when using partial matrixectomy and surgical interventions with phenol. Shorter duration of pain was reported with phenolisation and wedge resection. Participant satisfaction was high overall. This second paper reports secondary outcomes from a robust systematic review of randomised trials on surgical treatment of ingrown toenails. Despite the large volume of clinical trials conducted on the topic, few clinical conclusions can be drawn due to the poor quality of these studies. Further high-quality clinical trials are needed to answer fundamental questions in the surgical treatment of ingrown toenails.

Sections du résumé

BACKGROUND BACKGROUND
When performing nail surgery, clinicians must choose from a multitude of procedures and variations within each procedure. Much has been published to guide this decision making, but there are a lack of up to date robust systematic reviews to assess the totality of this evidence.
METHODS METHODS
Five databases (MEDLINE, Embase, CINAHL, Web of Science and CENTRAL) and two registers (Clinicaltrials.gov and ISRCTN) were searched to January 2022 for randomised trials evaluating the effects of a surgical intervention(s) for ingrown toenails. Two independent reviewers screened records, extracted data, assessed risk of bias and certainty of evidence. Data on co-primary outcomes of symptom relief and symptomatic regrowth were presented in our first paper. This paper presents data for the secondary outcomes and further discussion.
RESULTS RESULTS
Of 3,928 records identified, 36 randomised trials were included in the systematic review. Healing time appears to be reduced with shorter application of phenol. A reduced healing time was also apparent was with the addition of curettage, although this may also increase the risk of post-operative bleeding and pain. Post operative bleeding was also reportedly lower in people who received local anaesthetic with epinephrine but no tourniquet. Use of phenol with nail bed excision may decrease the risk of infection. Lower pain scores were reported when using partial matrixectomy and surgical interventions with phenol. Shorter duration of pain was reported with phenolisation and wedge resection. Participant satisfaction was high overall.
CONCLUSION CONCLUSIONS
This second paper reports secondary outcomes from a robust systematic review of randomised trials on surgical treatment of ingrown toenails. Despite the large volume of clinical trials conducted on the topic, few clinical conclusions can be drawn due to the poor quality of these studies. Further high-quality clinical trials are needed to answer fundamental questions in the surgical treatment of ingrown toenails.

Identifiants

pubmed: 37674170
doi: 10.1186/s13047-023-00655-7
pii: 10.1186/s13047-023-00655-7
pmc: PMC10481456
doi:

Substances chimiques

Phenol 339NCG44TV
Phenols 0

Types de publication

Meta-Analysis Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

55

Informations de copyright

© 2023. The College of Podiatry and the Australasian Podiatry Council.

Références

J Clin Med. 2020 Mar 20;9(3):
pubmed: 32244966
J Am Coll Surg. 2008 Jan;206(1):148-53
pubmed: 18155581
Arch Surg. 2002 Mar;137(3):320-5
pubmed: 11888459
Trials. 2022 Jun 2;23(1):458
pubmed: 35655288
Ann Intern Med. 2017 Jul 4;167(1):40-47
pubmed: 28630973
J R Coll Surg Edinb. 1990 Aug;35(4):240-2
pubmed: 2102672
Bone Joint J. 2021 Dec;103-B(12):1802-1808
pubmed: 34847717
Int J Dermatol. 2020 Jun;59(6):656-669
pubmed: 31970759
BMJ. 2012 Apr 03;344:e2089
pubmed: 22491483
J Bone Joint Surg Am. 2004 Jul;86(7):1366-74
pubmed: 15252082
Pol Przegl Chir. 2014 Feb;86(2):89-93
pubmed: 24670340
Indian J Dermatol. 2013 Jul;58(4):327
pubmed: 23919026
Hepatobiliary Surg Nutr. 2023 Aug 1;12(4):534-544
pubmed: 37601001
BMC Public Health. 2013 Jun 11;13:568
pubmed: 23758638
Int J Surg. 2016 Oct;34:1-5
pubmed: 27514456
Ann Surg. 2021 Jan 1;273(1):82-85
pubmed: 32649459
J Am Podiatr Med Assoc. 1992 Apr;82(4):221-3
pubmed: 1597834
J Bone Joint Surg Br. 1990 May;72(3):507-9
pubmed: 2341458
Surgery. 1990 May;107(5):566-7
pubmed: 2333596
Dermatol Surg. 2014 Nov;40(11):1214-20
pubmed: 25322163
J Ayub Med Coll Abbottabad. 2014 Oct-Dec;26(4):522-5
pubmed: 25672179
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
Dermatol Surg. 2012 Mar;38(3):454-61
pubmed: 22122781
J R Coll Surg Edinb. 1983 Sep;28(5):331-2
pubmed: 6644648
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Cochrane Database Syst Rev. 2012 Apr 18;(4):CD001541
pubmed: 22513901
Int J Environ Res Public Health. 2021 Oct 06;18(19):
pubmed: 34639778
BMJ. 2013 Jun 18;346:f2820
pubmed: 23778425
Int J Low Extrem Wounds. 2015 Jun;14(2):192-5
pubmed: 25256283
J Dermatol. 2018 Dec;45(12):1418-1424
pubmed: 30264897
Br J Surg. 1988 Feb;75(2):181-3
pubmed: 3349312
Dermatol Surg. 2011 Mar;37(3):331-5
pubmed: 21324043
Dermatol Surg. 2010 Oct;36(10):1568-71
pubmed: 20698866
BMJ. 1994 Jan 29;308(6924):283-4
pubmed: 8124111
Br J Clin Pract. 1990 Dec;44(12):562-3
pubmed: 2102144
JAMA Surg. 2017 Aug 01;152(8):784-791
pubmed: 28467526
Dermatol Surg. 2018 May;44(5):645-650
pubmed: 29701619
Clin Orthop Relat Res. 2008 Feb;466(2):424-31
pubmed: 18196427
Health Qual Life Outcomes. 2004 Jun 29;2:32
pubmed: 15225377
BMJ. 2004 Jun 26;328(7455):1561-3
pubmed: 15217878
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
BMJ. 2018 Nov 5;363:k3750
pubmed: 30560792
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
J Bone Joint Surg Br. 1991 Jan;73(1):131-3
pubmed: 1991748
Dermatol Ther. 2018 Sep;31(5):e12677
pubmed: 30134040
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
Foot Ankle Int. 2005 May;26(5):401-5
pubmed: 15913526
J Eur Acad Dermatol Venereol. 2022 Apr;36(4):526-535
pubmed: 34913204
J Eur Acad Dermatol Venereol. 2015 May;29(5):985-90
pubmed: 25284453
Acta Orthop Traumatol Turc. 2009 Aug-Oct;43(4):298-302
pubmed: 19809225
Acta Dermatovenerol Alp Pannonica Adriat. 2020 Jun;29(2):51-54
pubmed: 32566949
Dermatol Surg. 2013 Aug;39(8):1264-9
pubmed: 23631560
Arch Fam Med. 2000 Sep-Oct;9(9):930-2
pubmed: 11031403
Br J Surg. 1984 Jul;71(7):526-7
pubmed: 6375800
Value Health. 2005 Nov-Dec;8 Suppl 1:S6-8
pubmed: 16336490
Br J Surg. 2007 Mar;94(3):292-6
pubmed: 17318803
J Foot Ankle Res. 2023 Jun 10;16(1):35
pubmed: 37301845

Auteurs

Victoria Exley (V)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

Katherine Jones (K)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.

Grace O'Carroll (G)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

Judith Watson (J)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

Michael Backhouse (M)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK. Michael.backhouse@warwick.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH